Interactions amongst insulin, lipoproteins and haemostatic function relevant to coronary heart disease. by Hamsten, A, Karpe, F, Båvenholm, P, Silveira, A

Association of insulin and insulin propeptides with an atherogenic lipoprotein phenotype. by Båvenholm, P, Karpe, F, Proudler, A, Tornvall, P, Crook, D, Hamsten, A

Relationship of tissue factor pathway inhibitor activity to plasma lipoproteins and myocardial infarction at a young age. by Moor, E, Hamsten, A, Karpe, F, Båvenholm, P, Blombäck, M, Silveira, A

High-density lipoprotein: relations to metabolic parameters and severity of coronary artery disease. by Tornvall, P, Karpe, F, Proudler, A, Båvenholm, P, Landou, C, Olivecrona, T, Hamsten, A

A decrease in cardiovascular risk factors in healthy 40-year-old Swedish men between 1980-1983 and 1991-1992. by Tornvall, P, Båvenholm, P, Hellénius, M, Karpe, F, Regnström, J, de Faire, U